Detalhe da pesquisa
1.
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.
Br J Haematol
; 196(2): 356-359, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34528249
2.
Isolation of an Extract from the Soft Coral Symbiotic Microorganism Salinispora arenicola Exerting Cytoprotective and Anti-Aging Effects.
Curr Issues Mol Biol
; 44(1): 14-30, 2021 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35723381
3.
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
BMC Med
; 19(1): 208, 2021 08 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34420521
4.
Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin.
Blood
; 133(7): 710-723, 2019 02 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30482794
5.
Elucidating Carfilzomib's Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin.
Int J Mol Sci
; 22(20)2021 Oct 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34681615
6.
Osirisynes G-I, New Long-Chain Highly Oxygenated Polyacetylenes from the Mayotte Marine Sponge Haliclona sp.
Mar Drugs
; 18(7)2020 Jul 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32635268
7.
Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy.
Blood
; 139(9): 1409-1412, 2022 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34986251
8.
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
Blood
; 137(26): 3674-3676, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33861315
9.
Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
Am J Hematol
; 96(9): E321-E324, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34028867
10.
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
Am J Hematol
; 96(7): E257-E259, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33837984
11.
Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity.
Br J Pharmacol
; 2024 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38679957
12.
Cardiac mechanics in response to proteasome inhibition: a prospective study.
Eur Heart J Cardiovasc Imaging
; 24(5): 643-652, 2023 04 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35980754
13.
Autophagy activation can partially rescue proteasome dysfunction-mediated cardiac toxicity.
Aging Cell
; 21(11): e13715, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36259256
14.
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals.
Hemasphere
; 6(1): e677, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34938959
15.
Nrf2 activation induces mitophagy and reverses Parkin/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes.
Cell Death Dis
; 12(7): 671, 2021 07 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34218254
16.
Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
J Hematol Oncol
; 14(1): 86, 2021 05 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34059088
17.
Micro-CT for Biological and Biomedical Studies: A Comparison of Imaging Techniques.
J Imaging
; 7(9)2021 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34564098
18.
Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals.
Life (Basel)
; 11(10)2021 Oct 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34685448
19.
Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study.
Leukemia
; 35(5): 1418-1427, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33589757
20.
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.
Blood Cancer J
; 11(8): 138, 2021 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34341335